Skip to content
Trial Eligibility
Menu

Breast Cancer Clinical Trials near Houston, TX

184 studies for Breast Cancer are recruiting at 314 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Breast Cancer studies enrolling near Houston

Showing the 50 nearest of 184 studies.
  1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NCT05879926

    • Phase 3
    • Ages 18 to 60 years
    • Sex: Female

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  2. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    NCT05812807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  3. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    NCT04852887

    • Phase 3
    • Ages 50 to 70 years
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); Houston Methodist West Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  4. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    NCT06876714

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital (Houston, TX); Houston Methodist West Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  5. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT06058377

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  6. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson West Houston (Houston, TX); The University of Texas M. D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  7. QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

    NCT06551116

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  8. Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

    NCT00477100

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: M D Anderson Cancer Center (Houston, TX); MD Anderson in Katy (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  9. MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

    NCT03053193

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - Memorial City (Houston, TX); Texas Oncology Willowbrook (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  10. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    NCT06492616

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Harris Health System - Smith Clinic (Houston, TX); O'Quinn Medical Tower - McNair Campus (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  11. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    NCT07318805

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas - M.D. Anderson Cancer Center (Houston, TX); The University of Texas, MD Anderson Cancer Center - West Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  12. Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

    NCT04169542

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: M D Anderson Cancer Center (Houston, TX); MD Anderson in Sugar Land (Sugar Land, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    NCT07174336

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants P.A. (Houston, TX); Tranquility Research (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  14. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    NCT04389632

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, PA (Houston, TX); Oncology Consultants, PA. (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    NCT05696626

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine (Houston, TX); Harris Health System - Smith Clinic (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

    NCT06478589

    • Phase 2
    • Ages 65 to 100 years
    • Sex: Female

    Nearest sites: Memorial Hermann Cancer Center (Houston, TX); UT Physicians Family Medicine Bayshore (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

    NCT06764940

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); Tranquil Clinical Research (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  18. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    NCT06966700

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kelsey-Seybold Clinic ( Site 0042) (Houston, TX); Kelsey-Seybold Clinic ( Site 0088) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  19. A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

    NCT07062965

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson West Houston (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  20. ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

    NCT07173751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants PA (Houston, TX); Oncology Consultants PA (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  21. Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

    NCT03796559

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor Medicine (Houston, TX); MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

    NCT05020860

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Harris Health System - Smith Clinic (Houston, TX); O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

    NCT05232916

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest sites: Baylor College of Medicine - Dan L. Duncan Comprehensive Cancer Center (Houston, TX); Texas Oncology - Gulf Coast (Sugar Land, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  25. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    NCT05564377

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: Lyndon Baines Johnson General Hospital (Houston, TX); UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

    NCT05660083

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Neal Cancer Center (Houston, TX); The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  27. Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

    NCT05827081

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest sites: Kelsey Seybold Clinic (Houston, TX); University of Texas (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  28. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    NCT05929768

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  29. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, P.A. (Houston, TX); University of Texas M.D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  30. ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

    NCT06085833

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor College of Medicine (Houston, TX); MD Anderson Cancer Clinic - Mays Clinic (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  31. A Study of MGC026 in Participants With Advanced Solid Tumors

    NCT06242470

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    NCT06270706

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Houston (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  33. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    NCT06324357

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The Methodist Hospital Research Institute (Houston, TX); The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  34. Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

    NCT06380751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Houston, TX); Research Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  35. Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    NCT06393374

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants P.A. ( Site 0107) (Houston, TX); Texas Oncology - Gulf Coast ( Site 8009) (Webster, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  36. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    NCT06841354

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kelsey-Seybold Clinic ( Site 0040) (Houston, TX); Kelsey-Seybold Clinic - North Houston Campus ( Site 0096) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  37. Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    NCT06982521

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Hospital Cancer Center (Houston, TX); The University of Texas M.D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  38. ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

    NCT07007559

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Methodist Cancer Center (Houston, TX); The University of Texas M.D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  39. A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

    NCT07060807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants P.A. ( Site 0061) (Houston, TX); Texas Oncology - Gulf Coast ( Site 8006) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  40. A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

    NCT07287098

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Oncology Consultants P.A. (Houston, TX); University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  41. Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

    NCT07287917

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Lumi Research (Houston, TX); University of Texas-MD Anderson (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  42. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson (Houston, TX); NEXT Texas LLC - Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  43. Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

    NCT07524322

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Houston (Houston, TX); The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  44. Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

    NCT00991094

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

    NCT02918474

    • Interventional
    • Ages 18 years and older
    • Sex: Female

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

    NCT02945579

    • Interventional
    • Ages 30 years and older
    • Sex: Female

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

    NCT03408353

    • Observational
    • Ages 25 to 80 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. The PREDICT Registry:

    NCT03448926

    • Observational
    • Ages 30 to 85 years
    • Sex: Female

    Nearest site: Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

    NCT03604315

    • Phase 1
    • Ages 18 years and older
    • Sex: Female

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Breast Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.